Patents by Inventor Channing Joseph DER

Channing Joseph DER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY FOR TREATING ABNORMAL CELL GROWTH
    Publication number: 20250064804
    Abstract: The present invention relates, in part, to methods, compounds, and compositions of an autophagy pathway inhibitor in combination with a dual RAF/MEK inhibitor, for treating abnormal cell growth (e.g., cancer).
    Type: Application
    Filed: December 9, 2022
    Publication date: February 27, 2025
    Inventors: SANJIB CHOWDHURY, JONATHAN A. PACHTER, SILVIA COMA, KIRSTEN LEIGH BRYANT, CHANNING JOSEPH DER, WEN-HSUAN CHANG, JONATHAN MICHAEL DELIBERTY
  • METHODS FOR TREATING RAS DRIVEN CANCER IN A SUBJECT
    Publication number: 20090170837
    Abstract: The invention relates to the discovery that the dibenzodiazepinone analogues have growth inhibiting activities on tumorigenic cells that are driven by expression of RAS or mutated RAS. Thus the invention includes methods for inhibiting the activity of RAS using dibenzodiazepinone analogues; methods for inhibiting the growth of a RAS driven cancer cell using dibenzodiazepinone analogues; methods for inhibiting the growth of a RAS driven cancer using dibenzodiazepinone analogues; and methods for treating a subject having a RAS driven cancer using dibenzodiazepinone analogues.
    Type: Application
    Filed: October 24, 2008
    Publication date: July 2, 2009
    Applicant: THALLION PHARMACEUTICALS INC.
    Inventors: Henriette GOURDEAU, Pierre FALARDEAU, Nadia BOUFAIED, Paul Michael CAMPBELL, James John FIORDALISI, Adrienne Deich COX, Channing Joseph DER